The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
暂无分享,去创建一个
L. Staudt | A. Rosenwald | J. Powell | Liming Yang | W. Chan | T. Greiner | D. Weisenburger | J. Armitage | W. Wilson | J. Vose | R. Gascoyne | A. López-Guillermo | E. Campo | E. Montserrat | J. Connors | George W. Wright | G. Ott | H. Muller-Hermelink | E. Jaffe | J. Delabie | E. Smeland | R. Fisher | R. Simon | J. Giltnane | E. Hurt | Hong Zhao | Lauren Averett | R. Klausner | P. Duffey | D. Longo | W. Sanger | B. Dave | J. Lynch | T. Grogan | T. Miller | M. Leblanc | S. Kvaløy | H. Holte | P. Krajči | T. Stokke | M. LeBlanc | W. Wilson
[1] T. Grogan,et al. HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. , 1988, The Journal of clinical investigation.
[2] T. Grogan,et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67 , 1988 .
[3] M. Raffeld,et al. Detection of occult follicular lymphoma by specific DNA amplification. , 1988, Blood.
[4] F. Rilke,et al. Cell proliferation as a long‐term prognostic factor in diffuse large‐cell lymphomas , 1993, International journal of cancer.
[5] T M Grogan,et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[6] Gary R. Grotendorst. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts , 1997 .
[7] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Armitage,et al. International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Ash A. Alizadeh,et al. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. , 1999, Cold Spring Harbor symposia on quantitative biology.
[10] Emma Jones,et al. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma , 2000 .
[11] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[12] B. Coiffier,et al. Diffuse large cell lymphoma. , 2001, Current opinion in oncology.
[13] Ulrich Siebenlist,et al. Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells , 2001, The Journal of experimental medicine.
[14] A. Baldwin. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. , 2001, The Journal of clinical investigation.
[15] L. Staudt,et al. Signatures of the immune response. , 2001, Immunity.
[16] Ash A. Alizadeh,et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. , 2002, Blood.